Nirvana Life Sciences (XCNQ:NIRV) Dividend Payout Ratio : 0.00 (As of Jan. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nirvana Life Sciences Dividend Payout Ratio?

Nirvana Life Sciences's dividend payout ratio for the months ended in Jan. 2024 was 0.00.

The historical rank and industry rank for Nirvana Life Sciences's Dividend Payout Ratio or its related term are showing as below:

XCNQ:NIRV's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.435
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-17), the Dividend Yield % of Nirvana Life Sciences is 0.00%.

Nirvana Life Sciences's Dividends per Share for the months ended in Jan. 2024 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Nirvana Life Sciences Dividend Payout Ratio Historical Data

The historical data trend for Nirvana Life Sciences's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nirvana Life Sciences Dividend Payout Ratio Chart

Nirvana Life Sciences Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Apr22

Apr23

Dividend Payout Ratio

Get a 7-Day Free Trial

Nirvana Life Sciences Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Nirvana Life Sciences's Dividend Payout Ratio

For the Biotechnology subindustry, Nirvana Life Sciences's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nirvana Life Sciences's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nirvana Life Sciences's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Nirvana Life Sciences's Dividend Payout Ratio falls into.

Nirvana Life Sciences Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Nirvana Life Sciences's Dividend Payout Ratio for the fiscal year that ended in Apr. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Apr. 2023 )	/	EPS without NRI (A: Apr. 2023 )
	=	0	/	-0.033
	=	N/A

Nirvana Life Sciences's Dividend Payout Ratio for the quarter that ended in Jan. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jan. 2024 )	/	EPS without NRI (Q: Jan. 2024 )
	=	0	/	-0.002
	=	N/A

Nirvana Life Sciences (XCNQ:NIRV) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Nirvana Life Sciences Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Nirvana Life Sciences's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Nirvana Life Sciences (XCNQ:NIRV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nirvana Life Sciences Inc (XCNQ:NIRV) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8

Website

https://www.nirvanalifescience.com

Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.

Nirvana Life Sciences (XCNQ:NIRV) Headlines

No Headlines